Home/Filings/4/0001209191-23-008059
4//SEC Filing

HAJOST MICHAEL A 4

Accession 0001209191-23-008059

CIK 0001779020other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:00 PM ET

Size

14.3 KB

Accession

0001209191-23-008059

Insider Transaction Report

Form 4
Period: 2023-02-07
HAJOST MICHAEL A
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2023-02-07+38,65938,659 total
  • Tax Payment

    Class A Common Stock

    2023-02-07$2.53/sh13,686$34,62624,973 total
  • Exercise/Conversion

    RSU Award

    2023-02-0738,6590 total
    Class A Common Stock (38,659 underlying)
  • Exercise/Conversion

    RSU Award

    2023-02-0734,36468,728 total
    Class A Common Stock (34,364 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2023-02-07+34,36459,337 total
  • Tax Payment

    Class A Common Stock

    2023-02-07$2.53/sh10,561$26,71948,776 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On March 31, 2022, the reporting person was granted 38,659 restricted stock units, which are vesting on February 7, 2023.
  • [F3]On March 31, 2022, the reporting person was granted 103,092 restricted stock units. 34,364 restricted stock units are vesting on February 7, 2023, February 7, 2024, and February 7, 2025.

Issuer

Danimer Scientific, Inc.

CIK 0001779020

Entity typeother

Related Parties

1
  • filerCIK 0001437151

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:00 PM ET
Size
14.3 KB